Related references
Note: Only part of the references are listed.Validation of Computer-Adaptive Contrast Sensitivity as a Tool to Assess Visual Impairment in Multiple Sclerosis Patients
Sina C. Rosenkranz et al.
FRONTIERS IN NEUROSCIENCE (2021)
Cuprizone-Induced Neurotoxicity in Human Neural Cell Lines Is Mediated by a Reversible Mitochondrial Dysfunction: Relevance for Demyelination Models
Eva Martinez-Pinilla et al.
BRAIN SCIENCES (2021)
Effect of Fasudil on remyelination following cuprizone-induced demyelination
Jing Wang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model
Anna Nellessen et al.
METABOLIC BRAIN DISEASE (2020)
Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis
Danica Michalickova et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Nuclear Factor κB (NF-κB)-Mediated Inflammation in Multiple Sclerosis
Yifan Zhou et al.
FRONTIERS IN IMMUNOLOGY (2020)
Treatment and management of cognitive dysfunction in patients with multiple sclerosis
John DeLuca et al.
NATURE REVIEWS NEUROLOGY (2020)
The effect of the demyelinating agent cuprizone on binge-like eating of sweetened palatable food in female and male C57BL/6 substrains
Richard K. Babbs et al.
APPETITE (2020)
Cuprizone-Induced Demyelination in Mouse Hippocampus Is Alleviated by Ketogenic Diet
Chunhong Liu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)
Aquaporin-4 Expression during Toxic and Autoimmune Demyelination
Sven Olaf Rohr et al.
CELLS (2020)
Trifluoperazine an Antipsychotic Drug and Inhibitor of Mitochondrial Permeability Transition Protects Cytarabine and Ifosfamide-Induced Neurotoxicity
Amir Kiani et al.
DRUG RESEARCH (2020)
Agmatine ameliorates acetic acid-induced colitis in rats: involvement of nitrergic system
Amir Rashidian et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2019)
NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration
Michael G. Dorrington et al.
FRONTIERS IN IMMUNOLOGY (2019)
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination
Georgia Mandolesi et al.
NEUROBIOLOGY OF DISEASE (2019)
Antipsychotic Drug Trifluoperazine Suppresses Colorectal Cancer by Inducing G0/G1 Arrest and Apoptosis
Yong Xia et al.
FRONTIERS IN PHARMACOLOGY (2019)
Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis
Monokesh K. Sen et al.
CELLS (2019)
Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases
Jose M. Vega-Riquer et al.
CURRENT NEUROPHARMACOLOGY (2019)
Protective and therapeutic role of Bilobalide in cuprizone-induced demyelination
Ruo-Xuan Sui et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Cuprizone toxicity and Garcinia kola biflavonoid complex activity on hippocampal morphology and neurobehaviour
G. O. Omotoso et al.
HELIYON (2019)
Is there a Link between Vitamin B and Multiple Sclerosis?
Natalie Nemazannikova et al.
MEDICINAL CHEMISTRY (2018)
Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: A pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation
Eman M. Elbaz et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitis
Yuan Yue et al.
NEURAL REGENERATION RESEARCH (2018)
The Immunomodulatory and Anti-Inflammatory Role of Polyphenols
Nour Yahfoufi et al.
NUTRIENTS (2018)
Ameliorative effects of Moringa on cuprizone-induced memory decline in rat model of multiple sclerosis
Gabriel Olaiya Omotoso et al.
ANATOMY & CELL BIOLOGY (2018)
Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study
Heba R. Ghaiad et al.
MOLECULAR NEUROBIOLOGY (2017)
Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms
Benjamin M. Brucker et al.
NEUROUROLOGY AND URODYNAMICS (2017)
The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice
Chika Higashi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients
Livan Delgado-Roche et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
The mechanical importance of myelination in the central nervous system
Johannes Weickenmeier et al.
JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (2017)
Identification of Non-Electrophilic Nrf2 Activators from Approved Drugs
Qing-Ye Zhang et al.
MOLECULES (2017)
Hippocampal dysfunction is associated with memory impairment in multiple sclerosis: A volumetric and functional connectivity study
Julio Alberto Gonzalez Torre et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12/IL-17/IL-11 axis and restriction of mature oligodendrocytes apoptosis
Nima Sanadgol et al.
PHARMACEUTICAL BIOLOGY (2017)
Hippocampal dysfunction is associated with memory impairment in multiple sclerosis: A volumetric and functional connectivity study
Julio Alberto Gonzalez Torre et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Multiple Sclerosis: Immunopathology and Treatment Update
Narges Dargahi et al.
BRAIN SCIENCES (2017)
Participation Restriction in People With Multiple Sclerosis: Prevalence and Correlations With Cognitive, Walking, Balance, and Upper Limb Impairments
Davide Cattaneo et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2017)
The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination
Gelareh Vakilzadeh et al.
MOLECULAR NEUROBIOLOGY (2016)
Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function
Noemi Esteras et al.
BIOLOGICAL CHEMISTRY (2016)
New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis
Bozena Adamczyk et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
Saskia M. Leibowitz et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Cell type-specific Nrf2 expression in multiple sclerosis lesions
Simon Licht-Mayer et al.
ACTA NEUROPATHOLOGICA (2015)
Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of beta-TrCP and GSK-3
John D. Hayes et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Advances in the immunopathogenesis of multiple sclerosis
Sudhir K. Yadav et al.
CURRENT OPINION IN NEUROLOGY (2015)
An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders
Yang Yang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Unilateral and bilateral upper limb dysfunction at body functions, activity and participation levels in people with multiple sclerosis
Rita Bertoni et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
The cuprizone-induced changes in 1H-MRS metabolites and oxidative parameters in C57BL/6 mouse brain: Effects of quetiapine
Yinghua Xuan et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Unilateral and bilateral upper limb dysfunction at body functions, activity and participation levels in people with multiple sclerosis
Rita Bertoni et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Associations of Upper Limb Disability Measures on Different Levels of the International Classification of Functioning, Disability and Health in People With Multiple Sclerosis
Ilse Lamers et al.
PHYSICAL THERAPY (2015)
Macrophage subsets and microglia in multiple sclerosis
Jeroen F. J. Bogie et al.
ACTA NEUROPATHOLOGICA (2014)
Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases
Li Gan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Drug therapy for multiple sclerosis
Eleonora Tavazzi et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2014)
Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease
Robert E. Molokie et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
A comparative study of experimental mouse models of central nervous system demyelination
O. M. Dumitrascu et al.
GENE THERAPY (2014)
Ca2+-CaM regulating viability of Candida guilliermondii under oxidative stress by acting on detergent resistant membrane proteins
Bang An et al.
JOURNAL OF PROTEOMICS (2014)
ATLAS OF MULTIPLE SCLEROSIS 2013: A GROWING GLOBAL PROBLEM WITH WIDESPREAD INEQUITY
Paul Browne et al.
NEUROLOGY (2014)
Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis
Jelle Praet et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
Viktoria Gudi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Neuroprotection by Acetyl-11-Keto-β-Boswellic Acid, in Ischemic Brain Injury Involves the Nrf2/HO-1 defense Pathway
Yi Ding et al.
SCIENTIFIC REPORTS (2014)
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis
Gillian Ingram et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Neuroprotective Effects of Psychotropic Drugs in Huntington's Disease
Edward C. Lauterbach
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model
P. Acs et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Viruses and Multiple Sclerosis
Jussi Oskari Virtanen et al.
CNS & Neurological Disorders-Drug Targets (2012)
Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Wenge Li et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination
Neus Franco-Pons et al.
TOXICOLOGY LETTERS (2007)
The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia
L. A. Pasquini et al.
NEUROCHEMICAL RESEARCH (2007)
Trifluoperazine, an orally available clinically used drug, disrupts opioid antinociceptive tolerance
L Tang et al.
NEUROSCIENCE LETTERS (2006)
On the activity of trifluoperazine and palmitoylcarnitine in mice:: Delayed hypersensitivity models
L Góngora et al.
LIFE SCIENCES (2000)
Share Paper
